[go: up one dir, main page]

AR208179A1 - PROCEDURE FOR THE PRODUCTION OF (OMEGA-1) -OXOALKYLDIALKYLXANTHINES - Google Patents

PROCEDURE FOR THE PRODUCTION OF (OMEGA-1) -OXOALKYLDIALKYLXANTHINES

Info

Publication number
AR208179A1
AR208179A1 AR254209A AR25420974A AR208179A1 AR 208179 A1 AR208179 A1 AR 208179A1 AR 254209 A AR254209 A AR 254209A AR 25420974 A AR25420974 A AR 25420974A AR 208179 A1 AR208179 A1 AR 208179A1
Authority
AR
Argentina
Prior art keywords
oxoalkyldialkylxanthines
omega
procedure
production
Prior art date
Application number
AR254209A
Other languages
Spanish (es)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of AR208179A1 publication Critical patent/AR208179A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AR254209A 1973-06-16 1974-01-01 PROCEDURE FOR THE PRODUCTION OF (OMEGA-1) -OXOALKYLDIALKYLXANTHINES AR208179A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2330742A DE2330742C2 (en) 1973-06-16 1973-06-16 1- (Oxoalkyl) -3-methyl-7-alkylxanthines, process for their preparation and pharmaceuticals containing them

Publications (1)

Publication Number Publication Date
AR208179A1 true AR208179A1 (en) 1976-12-09

Family

ID=5884209

Family Applications (3)

Application Number Title Priority Date Filing Date
AR254209A AR208179A1 (en) 1973-06-16 1974-01-01 PROCEDURE FOR THE PRODUCTION OF (OMEGA-1) -OXOALKYLDIALKYLXANTHINES
AR260112A AR209319A1 (en) 1973-06-16 1975-08-22 PROCEDURE FOR THE PRODUCTION OF (OMEGA-1) -OXO-ALKYL-DIALKYLXANTHINES
AR260113A AR209320A1 (en) 1973-06-16 1975-08-22 PROCEDURE FOR THE PRODUCTION OF (OMEGA-1) -OXOALKYLDIALKYLXANTHINES

Family Applications After (2)

Application Number Title Priority Date Filing Date
AR260112A AR209319A1 (en) 1973-06-16 1975-08-22 PROCEDURE FOR THE PRODUCTION OF (OMEGA-1) -OXO-ALKYL-DIALKYLXANTHINES
AR260113A AR209320A1 (en) 1973-06-16 1975-08-22 PROCEDURE FOR THE PRODUCTION OF (OMEGA-1) -OXOALKYLDIALKYLXANTHINES

Country Status (17)

Country Link
US (1) US4289776A (en)
JP (1) JPS5233120B2 (en)
AR (3) AR208179A1 (en)
AT (1) AT334388B (en)
BE (1) BE816332A (en)
CH (2) CH608807A5 (en)
DE (1) DE2330742C2 (en)
DK (1) DK145676C (en)
ES (1) ES427171A1 (en)
FI (1) FI58920C (en)
FR (1) FR2233065B1 (en)
GB (1) GB1470220A (en)
IE (1) IE39898B1 (en)
NL (1) NL182806C (en)
NO (1) NO140300C (en)
SE (1) SE423631B (en)
ZA (1) ZA743760B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608236A5 (en) 1974-01-22 1978-12-29 Wuelfing J A Fa
DE2507554A1 (en) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7- (OXOALKYL) -1,3-DIALKYLXANTHINE, METHOD OF PREPARATION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE2507555A1 (en) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7- (OXOALKYL) -1,3-DIALKYLXANTHINE, THE METHOD OF MANUFACTURING THEREOF AND MEDICINAL PRODUCTS CONTAINING THIS COMPOUND
JPS54112893A (en) * 1978-02-21 1979-09-04 Kohjin Co Ltd Preparation of 1-(5'-oxohexyl)-3,7-diethylxanthine
DE2967632D1 (en) * 1978-04-22 1986-12-04 Beecham Wuelfing Gmbh & Co Kg Use of a xanthine derivate in the manufacture of a medicament
IL59665A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
DE3173289D1 (en) * 1980-06-21 1986-02-06 Beecham Wuelfing Gmbh & Co Kg Xanthine derivatives, pharmaceutical compositions containing them and a process for their preparation
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
JPH062675B2 (en) * 1985-04-05 1994-01-12 ヘキストジヤパン株式会社 Memory disorder treatment
GB8621869D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Treatment
JPS63225317A (en) * 1986-10-06 1988-09-20 Hoechst Japan Kk anti-peptic ulcer agent
IT1197516B (en) * 1986-12-24 1988-11-30 Abc Ist Biolog Chem Spa THEOFILLINMETYLANIC AND THEOFILLINMETYLDITIAN DERIVATIVES PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5096906A (en) * 1986-12-31 1992-03-17 University Of Virginia Alumni Patents Foundation Method of inhibiting the activity of leukocyte derived cytokines
CA2030112A1 (en) * 1989-11-24 1991-05-25 Yasuo Ito Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
DE3942872A1 (en) * 1989-12-23 1991-06-27 Hoechst Ag METHOD FOR THE ENANTIOSELECTIVE PRESENTATION OF ((OMEGA) -1) -HYDROXYALKYLXANTHINES
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
DK0514789T3 (en) * 1991-05-23 1997-02-17 Hoechst Ag
MX9203323A (en) * 1991-07-11 1994-07-29 Hoechst Ag THE USE OF XANTHINE DERIVATIVES FOR THE TREATMENT OF SECONDARY INJURIES OF THE NERVOUS CELLS AND FUNCTIONAL DISORDERS AFTER CRANIAL-BRAIN TRAUMA.
JP2549480B2 (en) * 1991-12-10 1996-10-30 ヘキストジャパン株式会社 Urinary disorder improving agent
EP0570831A2 (en) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Use of Xanthinderivatives for treatment of cerebral nerve dammages after disruption of the blood circulation
US5670506A (en) * 1993-04-05 1997-09-23 Cell Therapeutics, Inc. Halogen, isothiocyanate or azide substituted xanthines
US6020337A (en) * 1993-04-05 2000-02-01 Cell Therapeutics, Inc. Electronegative-substituted long chain xanthine compounds
WO1995020589A1 (en) * 1994-01-28 1995-08-03 Cell Therapeutics, Inc. Cell signaling inhibitors
US5762953A (en) * 1996-08-22 1998-06-09 Theratech, Inc. Transdermal propentofylline compositions for the treatment of Alzheimers disease
DE19707655A1 (en) * 1997-02-26 1998-08-27 Hoechst Ag Combination preparation for use in dementia
US20040110776A1 (en) * 2002-02-22 2004-06-10 Iok-Hou Pang Use of propentofylline to control intraocular pressure
WO2009108383A2 (en) 2008-02-29 2009-09-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
IN2012DN01642A (en) 2009-09-02 2015-06-05 Concert Pharmaceuticals Inc
EP3397640B1 (en) * 2015-12-29 2021-08-04 INSERM - Institut National de la Santé et de la Recherche Médicale Xanthine derivative inhibitors of bet proteins
CN112724160A (en) * 2021-03-19 2021-04-30 赤峰经方医药技术开发有限责任公司 Preparation method of pentoxifylline impurity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH325292A (en) * 1953-10-21 1957-10-31 Geigy Ag J R Process for the preparation of 7-oxyalkyl-xanthine derivatives
FR1211333A (en) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Improvements in processes for manufacturing oxyalkylxanthines
US3422107A (en) 1964-09-05 1969-01-14 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines and a process for the preparation thereof
US3737433A (en) 1964-09-05 1973-06-05 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines
DE1235320B (en) * 1964-09-05 1967-03-02 Albert Ag Chem Werke Process for the preparation of 1- (oxoalkyl) -3, 7-dimethylxanthines
DE1233405B (en) 1964-09-05 1967-02-02 Albert Ag Chem Werke Process for the preparation of 7- (oxoalkyl) -1, 3-dimethylxanthines
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
DE1810705C3 (en) * 1968-11-25 1980-11-27 Hoechst Ag, 6000 Frankfurt Stabilization of vitamins
DE1911279A1 (en) * 1969-03-05 1970-11-12 Eckert Dr Theodor Process to increase the ability of drugs to be absorbed

Also Published As

Publication number Publication date
NL182806B (en) 1987-12-16
AU7014774A (en) 1975-12-18
FR2233065B1 (en) 1978-07-21
FI58920C (en) 1981-05-11
GB1470220A (en) 1977-04-14
SE7407913L (en) 1974-12-17
FI58920B (en) 1981-01-30
NO140300C (en) 1979-08-08
IE39898B1 (en) 1979-01-31
DK145676C (en) 1983-08-01
CH608807A5 (en) 1979-01-31
DE2330742C2 (en) 1982-07-29
DK321574A (en) 1975-02-10
FI181974A7 (en) 1974-12-17
DE2330742A1 (en) 1975-01-09
SE423631B (en) 1982-05-17
NL7407890A (en) 1974-12-18
NO742121L (en) 1975-01-13
NL182806C (en) 1988-05-16
DK145676B (en) 1983-01-24
NO140300B (en) 1979-04-30
AT334388B (en) 1976-01-10
ATA491874A (en) 1976-05-15
AR209320A1 (en) 1977-04-15
JPS5233120B2 (en) 1977-08-26
ZA743760B (en) 1975-06-25
JPS5047992A (en) 1975-04-28
IE39898L (en) 1974-12-16
FR2233065A1 (en) 1975-01-10
ES427171A1 (en) 1976-07-16
CH612969A5 (en) 1979-08-31
US4289776A (en) 1981-09-15
AR209319A1 (en) 1977-04-15
BE816332A (en) 1974-12-16

Similar Documents

Publication Publication Date Title
AR208179A1 (en) PROCEDURE FOR THE PRODUCTION OF (OMEGA-1) -OXOALKYLDIALKYLXANTHINES
AR201880A1 (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF 2-BENZAMIDO-5-NITROTIAZOL
AR203878A1 (en) PROCEDURE FOR THE PREPARATION OF 1-PYRAZINYLOXY 2-HYDROXY-3-AMINOPROPANE COMPOUNDS
AR204928A1 (en) PROCEDURE FOR THE PREPARATION OF HETEROCICLIC (ALKYL-THIOALKYL) THIOUREAS
AR204996A1 (en) PROCEDURE FOR THE PREPARATION OF 5-METHYL-7-HYDROXY OR 7-ALCOXY-ISOFLAVONES
MX4592E (en) PROCEDURE FOR THE PREPARATION OF 1-ARYLOXY-2-HYDROXY-3-ALKINYLAMINOPROPANES
IT1029594B (en) PROCEDURE FOR THE PRODUCTION OF BENZOKIN
AR210725A1 (en) PROCEDURE FOR THE PREPARATION OF DIBENZOXEPINE DERIVATIVES
AR203188A1 (en) PROCEDURE FOR THE PREPARATION OF THENOTRIAZOLODIACEPINE DERIVATIVES
AR207022A1 (en) PROCEDURE FOR THE PREPARATION OF POLY-N-DIMETHYLIMINOALANE
IT1029578B (en) PROCEDURE FOR THE PRODUCTION OF SUBSTITUTED PIRAZOLS
AR206632A1 (en) PROCEDURE FOR THE PREPARATION OF D-HOMOSTEROIDS
AR211918A1 (en) METHOD FOR THE PREPARATION OF N-CARBAMOIL-2-PHENYLETENSULFONAMIDE
AR207450A1 (en) PROCEDURE FOR THE PRODUCTION OF DERIVATIVES OF 4-FENYLSULFONYL-METHYL-PREHIDROINDAN-5-ONAS
AR206658A1 (en) PROCEDURE FOR THE PRODUCTION OF NEW DIARYLOXY-IMIDAZOLYLACETALS
IT1005996B (en) PROCEDURE FOR THE PRODUCTION OF CUMOLUS
AR203196A1 (en) PROCEDURE FOR THE PREPARATION OF IMIDAZOL-5-CARBOXAMIDOXIME DERIVATIVES
AR200171A1 (en) PROCEDURE FOR THE PRODUCTION OF NEW BENZOYLPHENYLGUANIDINES
AR198586A1 (en) PROCEDURE FOR THE PRODUCTION OF 5-NITRO-NAFTOQUINONE- (1,4)
AR203359A1 (en) PROCEDURE FOR THE PRODUCTION OF NEW N '- (AMINOACILAMINOPHENIL) -ACETAMIDINES
IT1018640B (en) PROCEDURE FOR THE PRODUCTION OF N ALCYLPIPERAZINES
AR200552A1 (en) PROCEDURE FOR THE PRODUCTION OF 1-OMEGA-CYANOALKYLCARBAMOYL-2-ACYLAMINE-BENZIMIDAZOLES
AR199824A1 (en) PROCEDURE FOR THE PRODUCTION OF NEW BENZOYLPHENYLISOTIOUREAS
AR213076A1 (en) PROCEDURE FOR THE PRODUCTION OF DERIVATIVES OF THE SUBSTITUTED GLICILGLICILANILIDE
ES550171A0 (en) PROCEDURE FOR THE PREPARATION OF MICROEN- CAPSULATED SPIRAMICINE